Animal research has suggested that liraglutide may also increase the risk of certain malignancies, such as thyroid cancer, but clinical studies are less definitive and continue to investigate whether these effects may also occur in humans [26]
Additionally, Faecalibacterium prausnitzii and its supernatant can promote the activity of the inflammasome containing Nod-like receptor protein 6, increase the secretion of IL-1, IL-18 and AMPs, thereby resisting C
However, with medication-induced rapid weight loss, the skin can struggle to keep up, leading to: Facial volume loss Temples, cheeks, and under-eye areas appear hollow
Management focuses on treating associated conditions such as diabetes, hypertension, and high cholesterol, with some diabetes medications like GLP-1 receptor agonists showing hepatic benefits in trials but remaining off-label for this indication
Available online: [DOI] [PMC free article] [PubMed] [Google Scholar] 8.US Preventive Services Task Force
